Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 166(12): 7112-20, 2001 Jun 15.
Article in English | MEDLINE | ID: mdl-11390456

ABSTRACT

Tissue factor (TF), the primary initiator of blood coagulation with structural homology to the cytokine receptor family, has been implicated in various vascular processes including metastasis, angiogenesis, and atherosclerosis. Within the vasculature, monocytes and endothelial cells (EC) can be activated to synthesize TF depending on the induction of NF-kappaB. Despite the undisputed value of cyclosporin A (CsA) as an immunosuppressant, problems have emerged due to induction of vascular changes by a poorly understood mechanism. We demonstrate that CsA has opposite effects on TF gene expression, inhibiting NF-kappaB-mediated TF gene transcription in monocytes but enhancing it in EC. To test whether CsA binding proteins (cyclophilins) can mediate these CsA effects we used a nonimmunosuppressant analog of CsA that binds to cyclophilins but does not inhibit the Ca2+/calmodulin-dependent phosphatase calcineurin (Cn). This drug lacked regulatory function for NF-kappaB and TF expression suggesting that Cn is responsible for the inverse gene regulation. The key function of Cn was supported by experiments demonstrating that other phosphatase inhibitors also either positively or negatively regulated NF-kappaB in monocytes and EC. Calcineurin was demonstrated to regulate NF-kappaB activation at the level of IkappaBalpha degradation, because agonist-induced phosphorylation and subsequent degradation of IkappaBalpha is prevented by Cn inhibitors in monocytes but enhanced in EC. These data identify Cn as an opposite regulator in generating transcriptionally active NF-kappaB, and they confirm the presumption that the ability of Cn to participate in NF-kappaB transactivation is not T cell specific.


Subject(s)
Calcineurin/physiology , Endothelium, Vascular/metabolism , Monocytes/metabolism , Thromboplastin/antagonists & inhibitors , Thromboplastin/biosynthesis , Calcineurin Inhibitors , Cells, Cultured , Cyclosporine/pharmacology , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Endothelium, Vascular/enzymology , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Gene Expression Regulation/drug effects , Humans , Monocytes/drug effects , Monocytes/enzymology , Peptidylprolyl Isomerase/metabolism , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/biosynthesis , Thromboplastin/genetics , Transcriptional Activation/drug effects , Umbilical Veins
2.
Electrophoresis ; 22(7): 1428-35, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11379967

ABSTRACT

A screening procedure for protein-protein interactions in cellular extracts using a green fluorescent protein (GFP) and affinity capillary electrophoresis (ACE) was established. GFP was fused as a fluorescent indicator to the C-terminus of a cyclophilin (rDmCyp20) from Drosophila melanogaster. Cyclophilins (Cyps) belong to the ubiquitously distributed enzyme family of peptidyl-prolyl cis/trans isomerases (PPlases) and are well known as cellular targets of the immunosuppressive drug cyclosporin A (CsA). The PPlase activity of the GFP fused rDmCyp20 as well as the high affinity to CsA remain intact. Using native gel electrophoresis and ACE mobility-shift assays, it was demonstrated that the known moderate affinity of Cyp20 to the capsid protein p24 of HIV-1 was detectable in the case of rDmCyp20 fused to the fluorescent tag. For the p24 / rDmCyp20-GFP binding an ACE method was established which allowed to determine a dissociation constant of Kd = 20+/-1.5 x 10(-6) M. This result was verified by size-exclusion chromatography and is in good agreement with published data for the nonfused protein. Moreover the fusion protein was utilized to screen rDmCyp20-protein interactions by capillary electrophoresis in biological matrices. A putative ligand of rDmCyp20 in crude extracts of embryonic D. melanogaster was discovered by mobility-shift assays using native gel electrophoresis with fluorescence imaging and ACE with laser-induced fluorescence detection. The approach seems applicable to a wide range of proteins and offers new opportunities to screen for moderate protein-protein interactions in biological samples.


Subject(s)
Electrophoresis, Capillary/methods , Proteins/analysis , Green Fluorescent Proteins , Luminescent Proteins , Protein Binding
3.
J Mol Biol ; 301(4): 1003-17, 2000 Aug 25.
Article in English | MEDLINE | ID: mdl-10966801

ABSTRACT

The 131-amino acid residue parvulin-like human peptidyl-prolyl cis/trans isomerase (PPIase) hPar14 was shown to exhibit sequence similarity to the regulator enzyme for cell cycle transitions human hPin1, but specificity for catalyzing pSer(Thr)-Pro cis/trans isomerizations was lacking. To determine the solution structure of hPar14 the (1)H, (13)C, and (15)N chemical shifts of this protein have been assigned using heteronuclear two and three-dimensional NMR experiments on unlabeled and uniformly (15)N/(13)C-labeled recombinant protein isolated from Escherichia coli cells that overexpress the protein. The chemical shift assignments were used to interpret the NOE data, which resulted in a total of 1042 NOE restraints. The NOE restraints were used along with 71 dihedral angle restraints and 38 hydrogen bonding restraints to produce 50 low-energy structures. The hPar14 folds into a betaalpha(3)betaalphabeta(2) structure, and contains an unstructured 35-amino acid basic tail N-terminal to the catalytic core that replaces the WW domain of hPin1 homologs. The three-dimensional structures of hPar14 and the PPIase domain of human hPin1 reveal a high degree of conservation. The root-mean-square deviations of the mean atomic coordinates of the heavy atoms of the backbone between residues 38 to 45, 50 to 58, 64 to 70, 81 to 86, 115 to 119 and 122 to 128 of hPar14 were 0.81(+/-0.07) A. The hPar14 model structure provides insight into how this class of PPIases may select preferential secondary catalytic sites, and also allows identification of a putative DNA-binding motif in parvulin-like PPIases.


Subject(s)
Catalytic Domain , Nuclear Magnetic Resonance, Biomolecular , Peptidylprolyl Isomerase/chemistry , Peptidylprolyl Isomerase/metabolism , Amino Acid Sequence , Binding Sites , Escherichia coli Proteins , Humans , Hydrogen Bonding , Immunophilins/chemistry , Models, Molecular , Molecular Sequence Data , Molecular Weight , NIMA-Interacting Peptidylprolyl Isomerase , Protein Binding , Protein Structure, Secondary , Protein Structure, Tertiary , Sequence Alignment , Sequence Homology, Amino Acid , Static Electricity , Structure-Activity Relationship , Surface Properties , Tacrolimus Binding Proteins
5.
Biochem J ; 334 ( Pt 3): 659-67, 1998 Sep 15.
Article in English | MEDLINE | ID: mdl-9729475

ABSTRACT

The immunosuppressive effects of the fungal metabolite cyclosporin A (CsA) are mediated primarily by binding to cyclophilins (Cyps). The resulting CsA-Cyp complex inhibits the Ca2+-regulated protein phosphatase calcineurin and down-regulates signal transduction events. Previously we reported that CsA is a potent inhibitor of infections transmitted by the human pathogenic protozoan parasite Leishmania major in vitro and in vivo, but does not effect the extracellular growth of L. major itself. It is unknown how L. major exerts this resistance to CsA. Here we report that a major Cyp, besides additional isoforms with the same N-terminal amino acid sequence, was expressed in L. major. The cloned and sequenced gene encodes a putative 174-residue protein called L. major Cyp 19 (LmCyp19). The recombinant LmCyp19 exhibits peptidyl-prolyl cis/trans isomerase activity with a substrate specificity and an inhibition by CsA that are characteristic of other eukaryotic Cyps. To determine whether calcineurin is involved in the discrimination of the effects of CsA we also examined the presence of a parasitic calcineurin and tested the interaction with Cyps. Despite the expression of functionally active calcineurin by L. major, neither LmCyp19 nor other L. major Cyps bound to its own or mammalian calcineurin. The amino acid sequence of most Cyps includes an essential arginine residue around the calcineurin-docking side. In LmCyp19 this is replaced by an asparagine residue. This exchange and additional charged residues are apparently responsible for the lack of LmCyp19 interaction with calcineurin. These observations indicate that resistance of L. major to CsA in vitro is mediated by the lack of complex formation with calcineurin despite CsA binding by parasitic Cyp.


Subject(s)
Calcineurin/metabolism , Isoenzymes/metabolism , Leishmania major/metabolism , Peptidylprolyl Isomerase/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , Cyclosporine/metabolism , Cyclosporine/pharmacology , DNA Primers/genetics , DNA, Protozoan/genetics , Escherichia coli/genetics , Genes, Protozoan , Humans , Immunosuppressive Agents/metabolism , Immunosuppressive Agents/pharmacology , In Vitro Techniques , Isoenzymes/antagonists & inhibitors , Isoenzymes/genetics , Kinetics , Leishmania major/drug effects , Leishmania major/genetics , Molecular Sequence Data , Peptidylprolyl Isomerase/antagonists & inhibitors , Peptidylprolyl Isomerase/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid
6.
Mol Microbiol ; 24(2): 421-9, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9159527

ABSTRACT

The antiparasitic effects of cyclosporin A were examined in leishmanial infection by analysing the role of CsA-binding proteins (cyclophilins) in the host-parasite interaction. We hypothesized that the leishmanicidal effects of CsA on Leishmania major infected macrophages might be mediated through a cyclophilin of either the parasite or the host cell. Two cyclophilins (20 and 22 kDa) were purified from L. major parasites and N-terminally sequenced. Although enzyme activity of these cyclophilins was inhibited by CsA, pretreatment of L. major parasites with CsA did not result in reduction of a subsequent macrophage infection, arguing against a role of L. major cyclophilins as infectivity potentiators. However, host-cell cyclophilin A (CypA) was found to be critically involved in the intracellular replication of L. major parasites in murine macrophages. An antisense oligonucleotide to murine CypA was constructed and added to cultures of peritoneal macrophages prior to infection with L. major parasites. This treatment strongly reduced the expression of CypA in macrophages and resulted in the inhibition of the intracellular replication of L. major amastigotes. These data indicate that interaction of amastigotes with host-cell cyclophilin is an important part of the intracellular replication machinery of L. major and define, for the first time, a direct involvement of a cyclophilin in the survival strategies of an intracellular parasite.


Subject(s)
Amino Acid Isomerases/physiology , Carrier Proteins/physiology , Host-Parasite Interactions/physiology , Leishmania major/growth & development , Leishmaniasis, Cutaneous/physiopathology , Amino Acid Isomerases/genetics , Amino Acid Isomerases/metabolism , Animals , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cells, Cultured , Cyclosporine/pharmacology , Gene Expression Regulation , Leishmania major/chemistry , Leishmaniasis, Cutaneous/genetics , Leishmaniasis, Cutaneous/metabolism , Macrophages, Peritoneal/parasitology , Mice , Mice, Inbred BALB C , Oligonucleotides, Antisense/pharmacology , Peptidylprolyl Isomerase , Transcription, Genetic
7.
Arch Dis Child ; 65(8): 885-7, 1990 Aug.
Article in English | MEDLINE | ID: mdl-2400228

ABSTRACT

Three children who presented with two rare conditions, nephrogenic diabetes insipidus and intracerebral calcification, were studied. The lack of evidence for the presence of a metabolic defect other than nephrogenic diabetes insipidus suggests that it can lead to the development of intracerebral calcification. Perhaps the main risk factor is inadequate fluid intake during early infancy.


Subject(s)
Brain Diseases/etiology , Calcinosis/etiology , Diabetes Insipidus/congenital , Brain/pathology , Brain Diseases/pathology , Calcinosis/pathology , Diabetes Insipidus/complications , Female , Humans , Infant, Newborn , Kidney Diseases/physiopathology , Kidney Tubules/physiopathology , Male , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...